Cannabidiol vs placebo
Adverse events · people with active UC
Cannabidiol probably leads to higher adverse events compared with placebo (moderate certainty).
1 finding from 1 review
- RR 1.28 [1.05, 1.56]1 study · 60 participantsModerate
Findings
What do systematic reviews say?
8 questions · 8 findings · 2 reviews · Gut
No studies found 5 · 62.5%GRADE not reported 0 · 0%Very low 1 · 12.5%Low 1 · 12.5%Moderate 1 · 12.5%High 0 · 0%
Cannabidiol vs placebo
Serious adverse events · people with active UC
Cannabidiol showed no clear difference in serious adverse events compared with placebo (low certainty).
1 finding from 1 review
- RR 0.15 [0.01, 2.83]1 study · 60 participantsLow
Cannabis oil (15% cannabidiol and 4% THC) vs placebo oil
Adverse events · Patients with active Crohn's disease
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Cannabis oil (5% cannabidiol sublingual oil) vs placebo oil
Adverse events · Patients with active Crohn's disease
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Cannabis oil (15% cannabidiol and 4% THC) vs placebo oil
Serious adverse events · Patients with active Crohn's disease
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Cannabis oil (5% cannabidiol sublingual oil) vs placebo oil
Serious adverse events · Patients with active Crohn's disease
It is very uncertain whether cannabis oil (5% cannabidiol sublingual oil) changes serious adverse events compared with placebo oil (very low certainty).
1 finding from 1 review
- RR 0.9 [0.07, 12.38]1 study · 19 participantsVery low
Cannabis oil (15% cannabidiol and 4% THC) vs placebo oil
Withdrawals due to adverse events · Patients with active Crohn's disease
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Cannabis oil (5% cannabidiol sublingual oil) vs placebo oil
Withdrawals due to adverse events · Patients with active Crohn's disease
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found